Seventeen-years overview of breast cancer inside and outside screening in Denmark

Acta Oncologica

Volumn 52, Issue 1, 2013, Pages 48-56

  Domingo, Laia ^a,b,c   Jacobsen, Katja Kemp ^a   Von Euler Chelpin, My ^a   Vejborg, Ilse ^d   Schwartz, Walter ^e   Sala, Maria ^b,c   Lynge, Elsebeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Rigshospitalet   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SCREENING; DENMARK; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOME ASSESSMENT; POPULATION; PRIORITY JOURNAL; REVIEW; TUMOR VOLUME; ARTICLE; CANCER PATIENT; CLINICAL FEATURE;

AGED; BREAST NEOPLASMS; DENMARK; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PROGNOSIS; PROGRAM EVALUATION; RECEPTORS, ESTROGEN;

EID: 84871450424     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.698750     Document Type: Review

References (25)

1. A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Hery C, et al. Disparities in breast cancer mortality trends between 30 European countries: Retrospective trend analysis of WHO mortality database. BMJ 2010;341:c3620.
3. Euler-Chelpin M. Breast cancer incidence and use of hormone therapy in Denmark 1978-2007. Cancer Causes Control 2011;22:181-7.
4. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. The decrease in breastcancer incidence in 2003 in the United States. N Engl J Med 2007;356:1670-4. (Pubitemid 46631679)
5. Bordas P, Jonsson H, Nystrom L, Lenner P. Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden. Breast 2007;16:47-54. (Pubitemid 46172856)
6. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg: Offi ce for Offi cial Publications of the European Communities; 2006.
7. Svendsen AL, Olsen AH, Euler-Chelpin M, Lynge E. Breast cancer incidence after the introduction of mammography screening: What should be expected? Cancer 2006;106: 1883-90. (Pubitemid 43673202)
8. Bennett RL, Sellars SJ, Moss SM. Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland. Br J Cancer 2011;104:571-7.
9. Bordas P, Jonsson H, Nystrom L, Lenner P. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden. J Med Screen 2009;16:39-45.
10. Tornberg S, Kemetli L, Ascunce N, Hofvind S, Anttila A, Seradour B, et al. A pooled analysis of interval cancer rates in six European countries. Eur J Cancer Prev 2010;19:87-93.
11. Bucchi L, Ravaioli A, Foca F, Colamartini A, Falcini F, Naldoni C. Incidence of interval breast cancers after 650,000 negative mammographies in 13 Italian health districts. J Med Screen 2008;15:30-5. (Pubitemid 351629544)
12. Utzon-Frank N, Vejborg I, Euler-Chelpin M, Lynge E. Balancing sensitivity and specifi city: Sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark. Cancer Epidemiol 2011;35:393-8.
13. Jensen A, Olsen AH, Euler-Chelpin M, Helle NS, Vejborg I, Lynge E. Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer 2005; 113:464-70. (Pubitemid 40038716)
14. Njor SH, Olsen AH, Bellstrom T, Dyreborg U, Bak M, Axelsson C, et al. Mammography screening in the county of Fyn. November 1993-December 1999. APMIS Suppl 2003; (110):1-33.
15. Domingo L, Sala M, Servitja S, Corominas JM, Ferrer F, Martinez J, et al. Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain. Cancer Causes Control 2010;21:1155-64.
16. Hofvind S, Geller B, Skaane P. Mammographic features and histopathological fi ndings of interval breast cancers. Acta Radiol 2008;49:975-81.
17. Vitak B, Olsen KE, Manson JC, Arnesson LG, Stal O. Tumour characteristics and survival in patients with invasive interval breast cancer classifi ed according to mammographic fi ndings at the latest screening: A comparison of true interval and missed interval cancers. Eur Radiol 1999;9:460-9.
18. Zackrisson S, Andersson I, Manjer J, Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 2004;108:754-60. (Pubitemid 38076408)
19. Euler-Chelpin M, Olsen AH, Njor S, Vejborg I, Schwartz W, Lynge E. Women's patterns of participation in mammography screening in Denmark. Eur J Epidemiol 2006;21: 203-9.
20. Njor SH, Olsen AH, Schwartz W, Vejborg I, Lynge E. Predicting the risk of a false-positive test for women following a mammography screening programme. J Med Screen 2007;14: 94-7. (Pubitemid 47067764)
21. Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Verbeek AL, Hendriks JH, et al. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 1999;81: 912-7. (Pubitemid 29504707)
22. Sarkeala T, Hakama M, Saarenmaa I, Hakulinen T, Forsman H, Anttila A. Episode sensitivity in association with process indicators in the Finnish breast cancer screening program. Int J Cancer 2006;118:174-9. (Pubitemid 41681595)
23. Hofvind S, Bjurstam N, Sorum R, Bjorndal H, Thoresen S, Skaane P. Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme. J Med Screen 2006;13:192-6. (Pubitemid 46057727)
24. Lawrence G, O'Sullivan E, Kearins O, Tappenden N, Martin K, Wallis M. Screening histories of invasive breast cancers diagnosed 1989-2006 in the West Midlands, UK: variation with time and impact on 10-year survival. J Med Screen 2009;16:186-92.
25. Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: A population based study. Breast Cancer Res 2012;14:R10.